The EBV is known to persist in memory B cells, but it remains unclear how this affects cell numbers and humoral immunity. We here studied EBV persistence in memory B cell subsets and consequences on B cell memory in young children. EBV genome loads were quantified in 6 memory B cell subsets in EBV + adults. 
effects of EBV infection on memory B cell numbers and vaccination responses were studied longitudinally in children within the Generation R population cohort between 14 mo and 6 yr of age. EBV genomes were more numerous in CD27 + IgG + , CD27 + IgA + , and B cells were significantly lower in EBV + children than in uninfected controls at 14 mo of age-the age when these cells peak in numbers. At 6 yr, all of these memory B cell counts had normalized, as had plasma IgG levels to previous primary measles and booster tetanus vaccinations. In conclusion, EBV persists predominantly in Ig class-switched memory B cells, even when derived from T cell-independent responses (CD27
Introduction
The EBV is a g-herpesvirus that is ubiquitous in the human population. Primary infection occurs predominantly in childhood. EBV selectively targets B cells through interactions with complement receptor 2 (CD21), MHC class II coreceptor surface molecules, or the b-1 integrin [1] [2] [3] . Even though all B cells express these molecules, EBV persists preferentially in memory B cells [4, 5] . It is thought that this is the result of EBV infection of activated B cells that undergo a T cell-dependent immune response in the GC, after which the virus persists in the long-lived memory B cell compartment [4, 6] . Other studies, however, indicate that in addition to the GC model of infection, memory B cells can be directly infected [7] [8] [9] [10] . Furthermore, there is evidence that EBV can also establish persistence in the absence of fully functional GC activity [11, 12] . Human memory B cells are phenotypically diverse. The majority originates from T cell-dependent GC responses: CD27 + IgD 2 IgM + "IgM-only," CD27 2 IgG + , CD27 + IgG + , and CD27 + IgA + memory B cells [13] . In addition, T cellindependent responses in the splenic marginal zone and the intestinal lamina propria can generate CD27 + IgD + IgM + "natural effector" and CD27 2 IgA + memory B cells, respectively [13, 14] . Primary EBV infection induces a strong expansion of memory B cells that decreases within 1 wk after the appearance of clinical complications [15] . Still, there is limited information about the preference of EBV to infect the diverse memory B cell populations and how EBV persistence affects the composition of the memory B cell compartment during latency [10, [15] [16] [17] . Importantly, in Western countries, ;40% of EBV infections occur in the first 5 yr of life, and numbers might be even higher in nonWestern countries and vary with differences in ethnicity [18, 19] . Especially during these first years of life, the memory B cell compartment is gradually built up [20] . Therefore, EBV infection in young children might affect a critical phase in the formation of immunologic memory, which could induce an immune imbalance and have long-term consequences [21] .
To address the effects of EBV on B cell memory, we here studied EBV persistence in all 6 memory B cell subsets, derived from T cell dependent and -independent responses, and we investigated, from a prospective birth cohort study, memory B cell counts in young children who were infected with EBV during the first years of life.
MATERIALS AND METHODS

Ethics statement
Ethical approval for the study was obtained from the Medical Ethical Committee of the Erasmus Medical Center, University Medical Center (Rotterdam, the Netherlands). Written, informed consent was obtained from all parents of participating children.
The Generation R population cohort
All analyses of EBV infection in children were conducted in the context of the Generation R Study, which is a prospective population-based cohort study from fetal life until young adulthood [22, 23] . In this study, a subgroup of 1182 Dutch children was included from whom detailed immunophenotyping data were available.
Detection of EBV genomes in isolated memory B cell subsets in EBV + adults
Buffy-coat material of 5 adult, EBV + blood donors was obtained from Sanquin (Amsterdam, the Netherlands), and mononuclear cells were isolated by Ficolldensity gradient separation. Genomic DNA was isolated (Sigma-Aldrich, St. Louis, MO, USA) from 3 million mononuclear cells to determine the presence of EBV genomes with a quantitative PCR specific for the BALF5 gene encoding EBV DNA polymerase [12, 24] . The remaining post-Ficoll mononuclear cells were presorted using human CD19 + MicroBeads (Miltenyi Biotec, San Diego, CA, USA) on an autoMACS system and stored in liquid nitrogen. From EBV-positive donors, the CD19 + B cells were thawed, and B cell subsets were purified after labeling with CD38-PE-Cy7 (clone HB7), CD24-APC-H7 (ML5), CD19-PerCP-Cy5.5 (SJ25C1), CD27-APC (L128), IgD-Pacific Orange (IA6-2), and IgM-Pacific Blue (G20-127), IgG-PE (G18-145; all from BD Biosciences, San Jose, CA, USA) and IgA-FITC (IS11-8E10; Miltenyi Biotec). Cell sorting with .95% cell-population purity was performed on a FACSAria I (BD Biosciences) using standardized measurement settings [25] . Genomic DNA was isolated, and EBV genome copies/10 6 isolated cells were determined as described above.
Flow cytometric immunophenotyping
Peripheral blood of children was obtained at the mean ages of 0 (cord blood; n = 220), 6 (n = 376), 14 (n = 241), 25 (n = 257), or 72 (n = 916) mo for detailed immunophenotyping. With 1-5 measurements per child, this resulted in a total of 2010 data points. Six memory B cell populations were defined [13] , using the following antibodies: CD19-PerCP (clone SJ25C1), CD27-APC-H7 (clone M-T27/L128), and IgM-APC (polyclonal; all from BD Biosciences); IgD-FITC (polyclonal) and IgG-PE (polyclonal; both SouthernBiotech, Birmingham, AL, USA); and IgA-FITC (polyclonal; Bio-Rad, Hercules, CA, USA). Flow cytometry was performed on an LSR II (BD Biosciences) using standardized measurement settings [25] . Absolute numbers of CD19 + B cells per microliter of blood were obtained with a routine diagnostic lyse-no-wash protocol using Trucount beads (BD Biosciences) and measured on a FACSCalibur (BD Biosciences). These absolute total CD19 + B cell numbers were subsequently used to convert relative numbers of the various B cell subsets into absolute numbers.
EBV and measles serology
In a random subset of 214 Dutch children, plasma samples were available at 14 mo of age, and IgG antibody levels against the EBV-VCA were determined with enzyme-linked immunoassays (Euroimmun, Lübeck, Germany) [26] . When EBV serology was negative at 14 mo, and plasma samples were available, follow-up serology was performed at the age of 6 yr. EBV positivity was determined based on a ratio of 0.8 of the sample over a manufacturerprovided reference threshold sample. In 132 of these 214 children, additional plasma samples were available at the age of 6 yr, and anti-measles and antitetanus IgG levels could be determined (Euroimmun). As per the manufacturer's instructions, the presence of .275 IU/ml for measles or 0.5 IU/ml for tetanus was defined as protective vaccination responses.
Statistical analysis
Relative means, cell medians, and proportions of protective vaccination responses between EBV 2 and EBV + groups were compared using the paired t test, Mann-Whitney U test, or Fisher's exact test, as indicated in figure legends. As the selection of the memory B cell populations to include in the analyses (see Figs. 2-4) was strongly dependent on the results we obtained (see Fig. 1 , a correction for multiple comparisons was considered not to be required. P , 0.05 was considered statistically significant. To model the memory B cell dynamics between birth and the age of 6 yr (see Fig. 2 ), linear mixed-effect analyses were performed on the relationship between the age of the children and the size of individual memory B cell populations. By including random effects in the model, this approach enabled modeling of cross-sectional data, with further improvement of the accuracy by incorporating longitudinal follow-up data from individual children taking the correlation between repeated measurements within individuals over time into account (and allowing for incomplete outcome data). To capture the trend in the data more precisely, we included a natural spline with different knots (0-3 knots) into the models. Positions of the knots in the 1-knot model were defined as the 50th percentile (25.5 mo); the 2-knots model at 33rd and 66th percentiles (14.1 and 70 mo); and the knots in the 3-knot model defined manually at 6, 14, and 24 mo, focusing around the time points of data inclusion. Model selection was performed by a likelihood ratio test. Statistical analyses were performed in R (version R-3.2.1) [27] .
RESULTS AND DISCUSSION
EBV persists in IgA + and IgG + class-switched memory B cells in adults
We first set out to test whether EBV preferentially persists in 1 of the 8 previously defined B cell populations in human blood [13] . As this required large volumes of blood (;500 ml), and these cannot safely be obtained from young children, we analyzed EBV persistence in memory B cell populations in adults. (Fig. 1A) . The viral loads in each subset from 5 EBV + adults were determined as absolute numbers of EBV genomes/million cells (Fig. 1B) 2 IgA + memory B cells appear to originate through GC-independent maturation pathways in local mucosal tissue [13, 28] . Therefore, the observation that these mucosa-derived CD27
2 IgA + memory B cells contained among the highest number of EBV copies, fits with the oral pathway of EBV infection.
Previously and in line with our results, small amounts of EBV genomes were also detected in natural effector B cells that originate from T cell-independent responses in the splenic marginal zone [11, 14, 29] . Our findings of EBV persistence in natural effector and CD27
2 IgA + memory B cell subsets, therefore, strengthen the suggestion that EBV can enter the memory B cell reservoir without the need for GC transit [4, 6, 30] . Whereas memory B cells are susceptible to EBV infection in vitro [3, 7, 11] and may be directly infected in vivo [8, 9] , recent mathematical descriptions for EBV persistence do not support this direct infection model [31] . More likely, EBV is prone to infect naive B cells that have been activated with or without T cell help and persists in the memory B cells that are derived from these responses. This "activation model" extends the currently existing models [4, 6, 11, 12] and accounts for the multiple (GC-dependent and -independent) ways by which EBV can access memory B cells.
The memory B cell subsets that we studied are generated by parallel pathways and are present in both children and adults. As there is, to our knowledge, no literature describing selective persistence of EBV in memory B cell subsets with increasing age, we think it is safe to assume that EBV persists in the same subsets in children and adults. + memory B cells with paired t tests. *P , 0.05; **P , 0.01; ****P , 0.0001.
Dynamics of memory B cells in the first 2 yr of life
In previous transversal studies, it has been found that memory B cells gradually accumulate in the first years of life [20, 32, 33] . We performed linear mixed-effect modeling of memory B cell population dynamics in 1182 children between birth and 6 yr of age in the context of the Generation R Study (Fig. 2) . The largest dynamics in population size were found in the first 2 yr of life for all memory B cell populations, which strongly increased in cell number. Whereas total B cell numbers subsequently reduce with ;50% between the age of 14 mo and 6 yr ( Fig. 3A and B, and data not shown), memory B cell numbers stabilized or showed only a gradual decline. Together, these effects result in a relative increase in the memory B cell population within the total B cell pool and are in line with previous literature [20, 32, 33] . As the greatest dynamics in memory B cell numbers were observed ;14 mo of age, it is conceivable that EBV infection has the greatest impact on B cell memory around this age.
Transient decline in memory B cells of EBVpositive children
To study whether EBV infection in the first year of life affects the dynamic development of memory B cells, we determined the naive and memory B cell counts in blood of 19 EBV + and 195 EBV 2 14-mo-old children ( (Fig. 3A) . Differences in the extent by which memory B cell populations were affected might be allocated to a variety of factors. First, differences in memory B cell dynamics during healthy B cell development might allow a faster normalization of certain memory B cell populations over others after EBV infection, potentially even explaining the nonsignificant reduction in CD27 2 IgA + memory B cell numbers in 14-mo-old EBV-infected children. Second, different frequencies of cells within each memory B cell population might be infected with EBV, thereby becoming targets for EBV-specific CD8 + T cell killing [7, 34] .
Last, distinct memory B cell populations might be differentially susceptible to cell death after EBV infection, either as a result of direct EBV-induced B cell death, because of differences in the efficiency of antigen presentation by distinct EBV-infected B cell populations, or as a result of the efficiency by which EBV-specific CD8 + T cells might recognize the different memory B cell populations [35] .
To test the long-term effects of the decline in memory B cell populations at the age of 14 mo, we performed follow-up analysis of the blood B cells of 146 of the children up to the age of 6 yr. At this age, 81 children were still EBV 2 , 52 became seropositive + memory, IgA + memory, or IgG + memory B cell subsets at the age of 6 yr in EBV 2 children (n = 81), children infected with EBV within the first 14 mo of age (early EBV + ; n = 13), and children infected with EBV between 1 and 6 yr of age (late EBV + ; n = 52). Bars depict median with interquartile range error bars. Significance was tested by Mann-Whitney U test relative to EBV 2 individuals. *P , 0.05; **P , 0.01; ***P , 0.001. ). Differences among continuous, normally distributed variables were compared by independent samples tests (2 groups) and one-way ANOVA (3 groups). Differences among categorical variables were compared with x 2 tests. Missing data at 14 mo: age, n = 1 (,1%); height (for age), n = 5 (2%); weight (for age), n = 2 (,1%); daycare, n = 27 (13%); breastfeeding, n = 3 (1%). Missing data at 6 yr: age, n = 4 (3%); gender, n = 4 (3%); height (for age), n = 4 (3%); weight (for age), n = 4 (3%); BMI for age, n = 4 (3%); CMV seropositivity, n = 5 (3%); HSV-1 seropositivity, n = 5 (3%); daycare, n = 25 (17%); breastfeeding, n = 6 (4%).
a P value reflects differences in characteristics between EBV 2 and EBV + children at 14 mo. b P value reflects differences in characteristics between EBV-seronegative, early and late EBV-seropositive children.
van den Heuvel et al. EBV-associated loss of memory B cells
www.jleukbio.org between 14 mo and 6 yr of age, and 13 were already infected within the first 14 mo of life. Regardless of early (,14 mo) or late (14 mo-6 yr) EBV infection, nearly all memory B cell counts were comparable with those in uninfected controls (Fig. 3B) . Only the numbers of IgM-only memory B cells were significantly lower in late EBV + than in EBV 2 children (31% decrease; Fig. 3B ).
Primary EBV infection was shown to result in a large relative expansion of EBV + B cells, which subsequently contracted, resulting in low frequencies of virus-carrying cells, 1 wk after appearance of clinical symptoms [15] . This depletion of virusexpressing cells is most likely the result of virus-induced or immune-mediated cell death. Furthermore, dysregulated cytokine or coreceptor signaling or impaired B cell differentiation has been suggested to associate with reduced memory B cell numbers and an impaired production of EBV-neutralizing antibodies in patients with acute symptomatic EBV infection [16] . The EBVinfected children in our study were, however, unlikely to be in the phase of acute infection, as they had a positive IgG serology against the VCA of EBV. As these antibodies typically appear 1 wk after acute infection and remain positive for life [36] , these children most likely were infected during their first year of life. Therefore, our observations extend the data in symptomatic, EBV-infected patients. Our data on long-term effects of EBV infection in young, asymptomatic children indicate that EBV-associated effects on memory B cells are transient.
Effects of B cell depletion on vaccination responses
Next, we measured IgG levels in plasma samples of 6-yr-old children to previous primary vaccination against measles and booster vaccination against tetanus. Both vaccinations are performed in the context of the Dutch national vaccination protocol [37] . In the Netherlands, the first measles vaccination is performed at the age of 14 mo when EBV + children show a decline in memory B cells. Tetanus vaccination is performed at the ages of 2, 3, 4, and 11 mo during the first year of life, followed by a booster at 4 yr (Fig. 4A) . Even though anti-measles responses have previously been described to be reduced at the age of 11 mo [38] , both the primary anti-measles (Fig. 4B ) and the boosted anti-tetanus (Fig. 4C ) IgG levels at 6 yr of age were similar among early EBV + , late EBV + , and EBV 2 children in our study.
Furthermore, the percentage of children with a protective response was similar among early EBV + , late EBV + , and EBV 2 children, with .80% (measles) and .67% (tetanus) of children having a protective titer at 6 yr. It is unlikely that natural exposure to measles or tetanus had a large effect on our observations, because of the .86% vaccination coverage in the Netherlands [39] . The last reported national measles outbreak was in 1999/2000, at least 2 yr before the children in our study were born [40] . The vast majority of infected children was not previously vaccinated, and a large-scale outbreak could be prevented as a result of the high overall vaccination coverage in the Netherlands [39] . Tetanus infection is rare in the Netherlands, with 5 or fewer reported cases of tetanus infection per year [41] . Therefore, it will be unlikely that natural exposure increased the anti-measles or anti-tetanus IgG titers and thereby influenced our results.
As antigen-specific memory B cell numbers correlate well with anti-measles IgG titers in the first years after vaccination [42] , our data suggest that despite a depletion in memory B cells, the remaining cells were sufficient to mount an antigen-specific response with protective IgG levels. Still, the outcomes we measured are of low resolution. We cannot exclude that highresolution approaches, such as next-generation sequencing, might identify restriction of the Ig gene repertoire after EBV-associated memory B cell depletion.
Conclusion
Altogether, our data indicate that EBV is able to persist in all class-switched memory B cell populations in blood, including the CD27 2 IgG + and CD27 2 IgA + memory B cells (the latter of which can be formed outside of a GC response), and that although early EBV infection is associated with a significantly smaller memory B cell expansion in the first year of life, long-term effects on the composition of the blood memory B cell compartment or its function in vaccination responses seem to be limited. 
